换一批
换一批摘要近几年国内外学者在小细胞肺癌(SCLC)的诊断分期、化放疗顺序、放疗参与综合治疗时间以及新的化疗药物、靶向药物应用等方面进行了广泛研究,尤其在广泛期SCLC化疗缓解后行脑预防照射的研究、新的化疗药物如伊立替康、口服拓扑替康、培美曲塞的应用等方面进行了有益的探索.但在有关分期、局限期SCLC化放疗时间等问题尚有争议,需进一步探讨和研究.
更多相关知识
abstractsRecently,staging,chemoradiotherapy schedule,new chemotherapy agents and application of targeted therapy drugs are widely investigated in small cell lung cancer(SCLC).Some progresses are achieved in prophylactic cranial irradiation of extensive stage and some new chemotherapy agents such as irinotecan,oral topotecan and pemetrexed etc are widely investigated.There are still some disputes about staging,the timing of chemoradiotherapy in localized SCLC and so on.
More相关知识
- 浏览478
- 被引1
- 下载360
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
